Close Menu

arbitration

The immune sequencing firm has engaged the FDA in discussions over how to get regulatory approval for one test for several seemingly different diseases.

The companies were involved in a dispute over NeoGenomics' handling of Health Discovery technology it licensed in 2012 to develop cancer tests.

Bio-Rad brought a claim before the American Arbitration Association in 2014, alleging that three 10X Genomics founders breached certain contractual obligations.

NEW YORK (GenomeWeb) – CareDx disclosed in a regulatory filing on Thursday that Roche is seeking an estimated $3.5 million from the firm for allegedly breaching a licensing deal the companies brokered in 2004.

NEW YORK (GenomeWeb) – Med BioGene today announced that it is ready to initiate proceedings against its commercial partner Precision Therapeutics to enforce a C$1 million (US$920,000) milestone payment due to Med BioGene.

NEW YORK (GenomeWeb News) – Sequenom's former President and CEO Harry Stylli has made an arbitration demand with the company, seeking more than $1.6 million in damages.

NEW YORK (GenomeWeb News) – Oxford Nanopore Technologies said today in its annual report that a commercialization agreement it had with Illumina will terminate on June 30, 2016.

In an intellectual property lawsuit filed by Cepheid against Roche, a US district court has stayed a hearing on whether a PCR patent owned by Roche is invalid until the companies finish ongoing arbitration hearings.

NEW YORK (GenomeWeb News) — In an intellectual property lawsuit brought against Roche by Cepheid, a federal court has ordered that a hearing be delayed on whether a PCR patent owned by Roche is invalid and expired until an outcome is achieved in arbitration proceedings between the companies.

NEW YORK (GenomeWeb News) – Life Technologies has filed a suit asking a federal court to find that the firm does not infringe a patent held by Promega and it has retained rights under a licensing agreement related to cell line authentication and identification.

Pages

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.